Shareholder Class Action

     Directors of Facet Biotech failed to maximize shareholder value in a proposed deal with Biogen Idec, Facet shareholders claim in San Diego Superior Court.




     
     Alfacell inflated its share price with false and misleading statements about its experimental cancer drug, Onconase, a class action claims in Trenton, N.J., Federal Court.
     
     Directors of Men’s Wearhouse dumped shares at prices inflated by false and misleading statements, shareholders claim in Houston Federal Court.
     
     SpongeTech Delivery Systems inflated its share price through false and misleading statements, shareholders claim in Manhattan Federal Court.
     
     Directors of EnergySolutions inflated its share price through false and misleading statements, shareholders claim in Manhattan Federal Court.
     
     RHI Entertainment inflated its share price through false and misleading statements, shareholders claim in Manhattan Federal Court.
     
     Affiliated Computer Services’ proposed merger with Xerox is unfair, ACS shareholders claim in Dallas County Court.

%d bloggers like this: